These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 10770275)

  • 41. Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8.
    Wang Q; Dziarski R; Kirschning CJ; Muzio M; Gupta D
    Infect Immun; 2001 Apr; 69(4):2270-6. PubMed ID: 11254583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IFNs activate toll-like receptor gene expression in viral infections.
    Miettinen M; Sareneva T; Julkunen I; Matikainen S
    Genes Immun; 2001 Oct; 2(6):349-55. PubMed ID: 11607792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.
    Zarember KA; Godowski PJ
    J Immunol; 2002 Jan; 168(2):554-61. PubMed ID: 11777946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses.
    Kirschning CJ; Bauer S
    Int J Med Microbiol; 2001 Sep; 291(4):251-60. PubMed ID: 11680785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.
    Mempel M; Voelcker V; Köllisch G; Plank C; Rad R; Gerhard M; Schnopp C; Fraunberger P; Walli AK; Ring J; Abeck D; Ollert M
    J Invest Dermatol; 2003 Dec; 121(6):1389-96. PubMed ID: 14675188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells.
    Tsuboi N; Yoshikai Y; Matsuo S; Kikuchi T; Iwami K; Nagai Y; Takeuchi O; Akira S; Matsuguchi T
    J Immunol; 2002 Aug; 169(4):2026-33. PubMed ID: 12165529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components.
    Talreja J; Kabir MH; B Filla M; Stechschulte DJ; Dileepan KN
    Immunology; 2004 Oct; 113(2):224-33. PubMed ID: 15379983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptors and other links between innate and acquired alloimmunity.
    Goldstein DR
    Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Signaling danger: toll-like receptors and their potential roles in kidney disease.
    Anders HJ; Banas B; Schlöndorff D
    J Am Soc Nephrol; 2004 Apr; 15(4):854-67. PubMed ID: 15034087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.
    Takeuchi O; Hoshino K; Akira S
    J Immunol; 2000 Nov; 165(10):5392-6. PubMed ID: 11067888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence.
    O'Neill L
    Biochem Soc Trans; 2000 Oct; 28(5):557-63. PubMed ID: 11044374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation.
    Hausmann M; Kiessling S; Mestermann S; Webb G; Spöttl T; Andus T; Schölmerich J; Herfarth H; Ray K; Falk W; Rogler G
    Gastroenterology; 2002 Jun; 122(7):1987-2000. PubMed ID: 12055604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis.
    Baker BS; Ovigne JM; Powles AV; Corcoran S; Fry L
    Br J Dermatol; 2003 Apr; 148(4):670-9. PubMed ID: 12752123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bacterial infections and toll-like receptors].
    Akira S
    Kekkaku; 2001 Aug; 76(8):593-600. PubMed ID: 11558139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2.
    Yang RB; Mark MR; Gurney AL; Godowski PJ
    J Immunol; 1999 Jul; 163(2):639-43. PubMed ID: 10395652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K
    J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways.
    Hazeki K; Masuda N; Funami K; Sukenobu N; Matsumoto M; Akira S; Takeda K; Seya T; Hazeki O
    Eur J Immunol; 2003 Mar; 33(3):740-7. PubMed ID: 12616494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll IL-1 receptors differ in their ability to promote the stabilization of adenosine and uridine-rich elements containing mRNA.
    Datta S; Novotny M; Li X; Tebo J; Hamilton TA
    J Immunol; 2004 Aug; 173(4):2755-61. PubMed ID: 15294994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells.
    Re F; Strominger JL
    J Immunol; 2004 Dec; 173(12):7548-55. PubMed ID: 15585882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.